# Heron Therapeutics, Inc.: Form 8-K, filed Nov 4, 2024

- Company: [Heron Therapeutics, Inc.](/companies/hrtx.md) (CIK 818033)
- Form: 8-K
- Filed: 2024-11-04
- Accepted by EDGAR: Nov 4, 2024, 17:09 ET
- Period: 2024-11-04
- Accession: 0000950170-24-120902
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/hrtx-20241104.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/hrtx-20241104.htm

Filed Nov 4, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-120902. Last ingested by Listed: Oct 27, 2026, 17:10 ET. No prices; not investment advice.